Hypoactive sexual desire disorder: The ideal patient for treatment with flibanserin

Chief, Division of Behavioral Medicine
Department of OB/GYN
MacDonald Women’s Hospital
University Hospitals Cleveland Medical Center
Professor, Departments of Reproductive Biology and Psychiatry
Case Western Reserve University School of Medicine
Cleveland, Ohio

Dr. Kingsberg reports receiving grant or research support from Palatin and Endoceutics; being a consultant to Valeant Pharmaceuticals, Palatin, Strategic Science Technologies, Emotional Brain, Endoceutics, AMAG, Pfizer, TherapeuticsMD, Duchesney, and IVIX; and being a speaker for Valeant Pharmaceuticals and AMAG.

Chief, Division of Behavioral Medicine
Department of OB/GYN
MacDonald Women’s Hospital
University Hospitals Cleveland Medical Center
Professor, Departments of Reproductive Biology and Psychiatry
Case Western Reserve University School of Medicine
Cleveland, Ohio

Dr. Kingsberg reports receiving grant or research support from Palatin and Endoceutics; being a consultant to Valeant Pharmaceuticals, Palatin, Strategic Science Technologies, Emotional Brain, Endoceutics, AMAG, Pfizer, TherapeuticsMD, Duchesney, and IVIX; and being a speaker for Valeant Pharmaceuticals and AMAG.

Chief, Division of Behavioral Medicine
Department of OB/GYN
MacDonald Women’s Hospital
University Hospitals Cleveland Medical Center
Professor, Departments of Reproductive Biology and Psychiatry
Case Western Reserve University School of Medicine
Cleveland, Ohio

Dr. Kingsberg reports receiving grant or research support from Palatin and Endoceutics; being a consultant to Valeant Pharmaceuticals, Palatin, Strategic Science Technologies, Emotional Brain, Endoceutics, AMAG, Pfizer, TherapeuticsMD, Duchesney, and IVIX; and being a speaker for Valeant Pharmaceuticals and AMAG.